Shantha Biotechnics Ltd

Rediff.com » News » Shantha Biotechnics Ltd

News for Shantha Biotechnics Ltd

Business

Now, a 4-in-1 vaccine from Shanta Biotech

Shantha Biotechnics Ltd on Friday announced the availability of 'Shantetra', a combination vaccine against diphtheria, tetanus, pertussis and hepatitis-B, claimed to be the first indigenously......

Shantha Bio to raise $30m for trials

City-based Shantha Biotechnics Pvt Ltd is slated to raise close to $30 million from a strategic investor to further Phase I trials of its four monoclonal molecules for cancer treatment.Shantha will......

Shantha Bio to tap US market in 2005

Shantha Biotechnics Pvt Ltd plans to become the first Indian biopharma firm to tap the US market in 2005 by launching its Hepatitis-B vaccine 'Shanvac B' and AlphaFeto Protein test kit in that......

Govt earns huge tax from big corporate deals

As corporate India unlocks value through mega deals, the Union government is smiling all the way to the bank.The government is likely to earn Rs 7,000 crore (Rs 70 billion) tax in the current......

More cases of tax evasion in cross border deals

The government said it has identified a few more cross-border merger and acquisition cases, including Barclays-Intelnet deal, for possible tax evasion after slapping Rs 11,000-crore (Rs 110......

Web results for Shantha Biotechnics Ltd

Merely chugging along

Posted by Equitymaster The principal shareholders must explain why the company is not pumping in more moneys into capex and why they are content... ...

http://feeds.equitymaster.com/~r/TheOutsideView/~3/W08ywIuMdsU/detail.asp

Get a grip

FOR SOME children, nothing is funnier than getting diarrhoea. Juvenile creativity in the schoolyard has given way to a nearly endless catalogue of... ...

http://week.manoramaonline.com/cgi-bin/MMOnline.dll/portal/ep/theWeekContent.do?programId=10350676&channelId=-1073908026&contentId=14010775&tabId=13BV_ID=@@@

SC's Glivec ruling setback to foreign pharma firms

SC rejects Novartis's patent plea for Glivec, says it does not meet any standard of novelty or inventiveness Vidya Krishnan | C.H. Unnikrishnan... ...

http://www.livemint.com/Industry/Xo7O5oVcFxHEL98hO8oYHK/SCs-GLivec-ruling-setback-to-foreign-pharma-firms.html

See All

Rediff News

Shantha Biotechnics Ltd

News for Shantha Biotechnics Ltd

Now, a 4-in-1 vaccine from Shanta Biotech

Shantha Bio to raise $30m for trials

Shantha Bio to tap US market in 2005

Govt earns huge tax from big corporate deals

More cases of tax evasion in cross border deals

Top Coverage News

Indian Premier League - IPL 2013

Coverage: The Match-Fixing Episode II - spot-fixing trial

Sachin Tendulkar : Cup of praise overfloweth - Reactions

Complete coverage of Mumbai blasts

Decoding India’s Corruption Wars - Ajit Balakrishnan's Blog